Mandate

VINGE ADVISES IK VII FUND IN CONNECTION WITH ACQUISITION OF TELECOMPUTING FROM FERD CAPITAL

January 15, 2016

Vinge and the Norwegian law firm, Wiersholm are advising the IK VII Fund in connection with its investment in TeleComputing AS. The TeleComputing Group is a fast-growing supplier of complete IT solutions on the Nordic SMB market. TeleComputing provides market-leading and environmentally friendly solutions within IT operations management, outsourcing, IT OnDemand, cloud services and Software as a Service (SaaS) services. The subsidiary, Kentor conducts system integration operations and provides qualified industry and operations specialists, systems developers and IT advisory services. The group has 860 employees at nine locations in four countries and has approximately 850 corporate customers in the Nordic region. The transaction is subject to customary closing conditions.

Vinge’s team consists of partner Jonas Bergström together with, among others, counsel Ulrich Ziche and associates Carl Sander, Joacim Rydergård, Sara Strandberg, Josefine Lanker, Karl-Johan Alvarsson and Joel Wahlberg and project assistant Caroline Skymberg. Partner Pär Remnelid and associate Ina Lunneryd are advising on the competition law regulatory aspects of the transaction.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025